Wang XW, Zhang FX, Yang F, Ding ZF, Agarwal N, Guo ZK, Mehta JL
Comparatively, non- GLP-1 users might not present the same challenges related to delayed gastric emptying and altered GI motility, potentially leading to more straightforward endoscopic procedures
Most people can, but it's always best to check with your provider to ensure there are no underlying conditions that could affect treatment
The aim of this article is to explore their clinical rationale, assess where they fit in the current guideline approach and identify which patients may derive benefit from their use
Glycemic Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonist on Top of Sodium-Glucose Co-Transporter-2 Inhibitor Treatment Compared to Sodium-Glucose Co-Transporter-2 Inhibitor Alone: A Systematic Review and Meta-Analysis of Randomized Controlled Trials